These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2694338)

  • 1. General considerations in the management of typhoid fever and dysentery.
    Gilman RH
    Scand J Gastroenterol Suppl; 1989; 169():11-8. PubMed ID: 2694338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical effect and laboratory observation of ofloxacin in the treatment of typhoid fever, bacillary dysentery and gonorrhea].
    Zou QY; Wang QN; Jiang YF
    Zhonghua Nei Ke Za Zhi; 1991 Sep; 30(9):572-4, 596. PubMed ID: 1806341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of typhoid fever and infectious diarrhoea with ciprofloxacin.
    Pithie AD; Wood MJ
    J Antimicrob Chemother; 1990 Dec; 26 Suppl F():47-53. PubMed ID: 2292545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftriaxone therapy in ciprofloxacin treatment failure typhoid fever in children.
    Dutta P; Mitra U; Dutta S; De A; Chatterjee MK; Bhattacharya SK
    Indian J Med Res; 2001 Jun; 113():210-3. PubMed ID: 11816954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonfluid therapy and selected chemoprophylaxis of acute diarrhea.
    Du Pont HL
    Am J Med; 1985 Jun; 78(6B):81-90. PubMed ID: 3893119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimethoprim-sulfamethoxazole in the treatment of gastrointestinal infections, including enteric fever and typhoid carriers.
    Geddes AM
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):35-6. PubMed ID: 805647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of bacillary dysentery, scarlet fever, and typhoid fever with Pantofenicol].
    Takahashi R; Nakamichi Y
    Nihon Densenbyo Gakkai Zasshi; 1967 Aug; 41(5):183-8. PubMed ID: 4967011
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and bacteriological profiles of patients with typhoid fever treated during 1975-1998 in the Tokyo Metropolitan Komagome Hospital.
    Hoshino Y; Masuda G; Negishi M; Ajisawa A; Imamura A; Hachimori K; Takayama N; Yamaguchi T; Kimura M
    Microbiol Immunol; 2000; 44(7):577-83. PubMed ID: 10981830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Typhoid fever: relapse due to antimicrobial resistance. Case report].
    Alecrim WD; Loureiro AC; Moraes RS; Monte RL; de Lacerda MV
    Rev Soc Bras Med Trop; 2002; 35(6):661-3. PubMed ID: 12612751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory characterisation of Salmonella enterica serotype Typhi isolates from Zimbabwe, 2009-2017.
    Mashe T; Gudza-Mugabe M; Tarupiwa A; Munemo E; Mtapuri-Zinyowera S; Smouse SL; Sooka A; Stray-Pedersen B; Smith AM; Mbanga J
    BMC Infect Dis; 2019 May; 19(1):487. PubMed ID: 31151421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The changing epidemiology of bacillary dysentery and characteristics of antimicrobial resistance of Shigella isolated in China from 2004-2014.
    Chang Z; Zhang J; Ran L; Sun J; Liu F; Luo L; Zeng L; Wang L; Li Z; Yu H; Liao Q
    BMC Infect Dis; 2016 Nov; 16(1):685. PubMed ID: 27863468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of typhoid fever caused by chloramphenicol-susceptible and chloramphenicol-resistant strains of Salmonella typhi to treatment with trimethoprim-sulfamethoxazole.
    Butler T; Rumans L; Arnold K
    Rev Infect Dis; 1982; 4(2):551-61. PubMed ID: 6981171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of treatment for dysentery, similar diseases and typhoid by a combined sulfamethoxazole-trimethoprim preparation].
    Akiba T; Tomisawa I; Hiraishi H; Ukai S; Matsubara Y
    Kansenshogaku Zasshi; 1972 May; 46(5):152-65. PubMed ID: 4629406
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic properties of R factors associated with epidemic strains of Shigella dysenteriae type I from Central America and Salmonella typhi from Mexico.
    Thorne GM; Farrar WE
    J Infect Dis; 1973 Jul; 128(1):132-6. PubMed ID: 4577973
    [No Abstract]   [Full Text] [Related]  

  • 15. Quinolones in Salmonella typhi infection.
    DuPont HL
    Drugs; 1993; 45 Suppl 3():119-24. PubMed ID: 7689442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial therapy of non-typhi salmonella and Shigella infection.
    Jewes LA
    J Antimicrob Chemother; 1987 May; 19(5):557-60. PubMed ID: 3301781
    [No Abstract]   [Full Text] [Related]  

  • 17. Randomized clinical trial of furazolidone for typhoid fever in children.
    Dutta P; Rasaily R; Saha MR; Mitra U; Manna B; Chakraborty S; Mukherjee A
    Scand J Gastroenterol; 1993 Feb; 28(2):168-72. PubMed ID: 8441910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro susceptibility of typhoid, paratyphoid and dysentery bacilli to aureomycin and chloramphenicol].
    ALIN K; WALLMARK G
    Nord Med; 1950 Apr; 43(16):663-4. PubMed ID: 14796936
    [No Abstract]   [Full Text] [Related]  

  • 19. An increase in enteric fever cases due to Salmonella Paratyphi A in & around Chandigarh.
    Gupta V; Kaur J; Chander J
    Indian J Med Res; 2009 Jan; 129(1):95-8. PubMed ID: 19287065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial enteric pathogens in children with acute dysentery in Thailand: increasing importance of quinolone-resistant Campylobacter.
    Bodhidatta L; Vithayasai N; Eimpokalarp B; Pitarangsi C; Serichantalergs O; Isenbarger DW
    Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):752-7. PubMed ID: 12757222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.